Noelia Martínez-Jáñez Selected Research

Docetaxel (Taxotere)

11/2015

Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Noelia Martínez-Jáñez Research Topics

Disease

6	Breast Neoplasms (Breast Cancer) 03/2023 - 11/2015
1	Breakthrough Infections 03/2023
1	COVID-19 03/2023
1	Hyperglycemia 01/2022
1	Vomiting 01/2022
1	Nausea 01/2022
1	Triple Negative Breast Neoplasms 01/2019

Drug/Important Bio-Agent (IBA)

3	Hormones (Hormone)IBA 08/2019 - 01/2016
2	Messenger RNA (mRNA)IBA 03/2023 - 03/2023
2	Fulvestrant (Faslodex)FDA Link 01/2022 - 08/2019
2	Aromatase InhibitorsIBA 01/2022 - 08/2019
1	2019-nCoV Vaccine mRNA-1273IBA 03/2023
1	Neutralizing AntibodiesIBA 03/2023
1	Cyclin-Dependent Kinase 4IBA 03/2023
1	COVID-19 VaccinesIBA 03/2023
1	Immunoglobulin G (IgG)IBA 03/2023
1	Biomarkers (Surrogate Marker)IBA 03/2023
1	sapanisertibIBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Anastrozole (Arimidex)FDA LinkGeneric 08/2019
1	130-nm albumin-bound paclitaxelIBA 01/2016
1	Epirubicin (Ellence)FDA LinkGeneric 11/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2015
1	Docetaxel (Taxotere)FDA Link 11/2015
1	Capecitabine (Xeloda)FDA Link 11/2015

Therapy/Procedure

3	Therapeutics 01/2022 - 11/2015
1	Drug Therapy (Chemotherapy) 01/2016